brivaracetam (CHEBI:133013)

ChEBI > Main

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name	brivaracetam

ChEBI ID	CHEBI:133013

Definition	A non-proteinogenic amino acid derivative that is butanamide in which the pro-S hydrogen at position 2 is replaced by a (4R)-2-oxo-4-propylpyrrolidin-1-yl. Used for treatment of partial onset seizures related to epilepsy.

Stars	This entity has been manually annotated by the ChEBI Team.

Supplier Information

Download	Molfile XML SDF

Wikipedia	License

Read full article at Wikipedia

Formula

C11H20N2O2

Net Charge

Average Mass

212.289

Monoisotopic Mass

212.15248

InChI

InChI=1S/C11H20N2O2/c1-3-5-8-6-10(14)13(7-8)9(4-2)11(12)15/h8-9H,3-7H2,1-2H3,(H2,12,15)/t8-,9+/m1/s1

InChIKey

MSYKRHVOOPPJKU-BDAKNGLRSA-N

SMILES

N1([C@H](C(N)=O)CC)C(C[C@H](C1)CCC)=O

Roles Classification
Application(s):	anticonvulsant A drug used to prevent seizures or reduce their severity.

ChEBI Ontology
Outgoing	brivaracetam (CHEBI:133013) has functional parent L-α-aminobutyric acid (CHEBI:35619) brivaracetam (CHEBI:133013) has role anticonvulsant (CHEBI:35623) brivaracetam (CHEBI:133013) is a γ-lactam (CHEBI:74222) brivaracetam (CHEBI:133013) is a non-proteinogenic amino acid derivative (CHEBI:83812)

IUPAC Name

(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide

INN	Source
brivaracetam	KEGG DRUG

Synonyms	Sources
2-(2-Oxo-4-propylpyrrolidin-1-yl)butanamide	ChemIDplus
UCB 34714	ChemIDplus
UCB34714	ChemIDplus

Brand Name	Source
Briviact	ChemIDplus

Last Modified

22 February 2017